This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
1Life Healthcare Future Growth
Future criteria checks 1/6
Key information
15.5%
Earnings growth rate
18.4%
EPS growth rate
| Healthcare earnings growth | 17.3% |
| Revenue growth rate | 19.0% |
| Future return on equity | -7.3% |
| Analyst coverage | Good |
| Last updated | n/a |
Recent future growth updates
Recent updates
Amazon receives FTC request for more information about One Medical deal
Sep 021Life Healthcare: Amazon Merger Unlikely To Face Regulatory Pushback
Aug 221Life Healthcare jumps after report of takeover interest
Jul 05Is 1Life Healthcare (NASDAQ:ONEM) A Risky Investment?
Jun 01
Is 1Life Healthcare (NASDAQ:ONEM) Weighed On By Its Debt Load?
Feb 261Life Healthcare: Not So Healthy Heading Into 2022
Jan 30Does 1Life Healthcare (NASDAQ:ONEM) Have A Healthy Balance Sheet?
Nov 141Life Healthcare: Post-Merger Earnings Preview
Sep 281Life Healthcare: Why We Are Against The Merger
Aug 191Life Healthcare: Some Questions After Recent Events
Jun 13Health Check: How Prudently Does 1Life Healthcare (NASDAQ:ONEM) Use Debt?
May 101Life Healthcare, Inc. (NASDAQ:ONEM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$54.00
Feb 28Can You Imagine How Jubilant 1Life Healthcare's (NASDAQ:ONEM) Shareholders Feel About Its 129% Share Price Gain?
Feb 01
1Life Healthcare Sets Foundation For Future Growth
Dec 31Are Insiders Selling 1Life Healthcare, Inc. (NASDAQ:ONEM) Stock?
Dec 181Life Healthcare Q3 2020 Earnings Preview
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1,823 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 1,626 | -285 | N/A | N/A | 4 |
| 12/31/2023 | 1,287 | -353 | -289 | -198 | 7 |
| 12/31/2022 | 1,046 | -398 | -286 | -212 | N/A |
| 9/30/2022 | 1,002 | -392 | -327 | -253 | N/A |
| 6/30/2022 | 891 | -359 | -283 | -217 | N/A |
| 3/31/2022 | 756 | -306 | -234 | -166 | N/A |
| 12/31/2021 | 623 | -255 | -152 | -89 | N/A |
| 9/30/2021 | 515 | -167 | -70 | -14 | N/A |
| 6/30/2021 | 465 | -105 | -37 | 19 | N/A |
| 3/31/2021 | 423 | -94 | -28 | 30 | N/A |
| 12/31/2020 | 380 | -89 | -68 | -4 | N/A |
| 9/30/2020 | 336 | -100 | -82 | -14 | N/A |
| 6/30/2020 | 304 | -99 | -101 | -27 | N/A |
| 3/31/2020 | 292 | -80 | -101 | -33 | N/A |
| 12/31/2019 | 276 | -53 | -86 | -32 | N/A |
| 9/30/2019 | 257 | -52 | -72 | -31 | N/A |
| 6/30/2019 | 237 | -45 | -56 | -29 | N/A |
| 3/31/2019 | 223 | -42 | -43 | -28 | N/A |
| 12/31/2018 | 213 | -44 | -29 | -18 | N/A |
| 12/31/2017 | 177 | -31 | -17 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ONEM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ONEM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ONEM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ONEM's revenue (19% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: ONEM's revenue (19% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ONEM is forecast to be unprofitable in 3 years.